Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits.

[1]  A. Azzi,et al.  Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. , 1996, Atherosclerosis.

[2]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[3]  A. Azzi,et al.  d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Azzi,et al.  Vitamin E: a sensor and an information transducer of the cell oxidation state. , 1995, The American journal of clinical nutrition.

[5]  A. Chait,et al.  Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[6]  I. Holme,et al.  Probucol treatment decreases serum concentrations of diet-derived antioxidants. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[7]  D. Steinberg.  Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? , 1995, The Lancet.

[8]  A. Azzi,et al.  Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. , 1995, Archives of biochemistry and biophysics.

[9]  N. Brindle,et al.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C , 1995, British journal of pharmacology.

[10]  D. Steinberg,et al.  Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase (*) , 1995, The Journal of Biological Chemistry.

[11]  Patrick,et al.  Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. , 1995, The Journal of clinical investigation.

[12]  E. Anggard,et al.  Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. , 1995, Atherosclerosis.

[13]  V. Kolpakov,et al.  Reduced smooth muscle cell regeneration in Yoshida (YOS) spontaneously hypercholesterolemic rats. , 1994, Atherosclerosis.

[14]  F. Kok,et al.  Antioxidants and coronary heart disease. , 1994, Annals of medicine.

[15]  D. Morel,et al.  Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. , 1994, The Journal of nutrition.

[16]  P. Demacker,et al.  Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[17]  E. Porreca,et al.  Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells. , 1993, Atherosclerosis.

[18]  T. Bocan,et al.  The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. , 1993, Atherosclerosis.

[19]  S. King,et al.  Probucol Decreases Neointimal Formation in a Swine Model of Coronary Artery Balloon Injury A Possible Role for Antioxidants in Restenosis , 1993, Circulation.

[20]  K. Prasad,et al.  Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. , 1993, Atherosclerosis.

[21]  M. Prosdocimi,et al.  Evidence for the presence of early vascular lesions in newborn Watanabe heritable hyperlipidemic (WHHL) rabbits. , 1993, Atherosclerosis.

[22]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[23]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[24]  P. Palozza,et al.  d‐α‐Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells , 1993 .

[25]  H. Stähelin,et al.  Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. , 1993, The American journal of clinical nutrition.

[26]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[27]  C. Hennekens,et al.  Antioxidants and heart disease: Epidemiology and clinical evidence , 1993, Clinical cardiology.

[28]  J. Swedenborg,et al.  Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. , 1993, The Journal of clinical investigation.

[29]  L. Packer,et al.  Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. , 1993, Biochimica et biophysica acta.

[30]  A. J. Valente,et al.  A modern view of atherogenesis. , 1993, The American journal of cardiology.

[31]  E. Anggard,et al.  Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Harris.  The prevention of atherosclerosis with antioxidants , 1992, Clinical cardiology.

[33]  C. Hensey,et al.  The protein kinase C family. , 1992, European journal of biochemistry.

[34]  D. Nierenberg,et al.  A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. , 1992, The American journal of clinical nutrition.

[35]  C. Tchervenkov,et al.  Oral vitamin E prophylaxis in the protection of newborn myocardium from global ischemia. , 1992, Surgery.

[36]  H. Stähelin,et al.  Nutritional factors correlating with cardiovascular disease: results of the Basel Study. , 1992, Bibliotheca nutritio et dieta.

[37]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[38]  A. Szewczyk,et al.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. , 1991, The Journal of biological chemistry.

[39]  A. Szewczyk,et al.  α-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity , 1991 .

[40]  G. Kopchok,et al.  Stenosis following laser thermal angioplasty--a blinded controlled randomized study between aspirin against Probucol. , 1991, The Journal of surgical research.

[41]  K. Gey.  The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. , 1990, Biochemical Society transactions.

[42]  P. Puska,et al.  Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology , 1989, Annals of the New York Academy of Sciences.

[43]  B. Caleb,et al.  Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells [published erratum appears in J Cell Biol 1990 Mar;110(3):863] , 1989, The Journal of cell biology.

[44]  H. Kuhn,et al.  The Role of the Low Density Lipoprotein Receptor for α‐Tocopherol Delivery to Tissues , 1989 .

[45]  A Daugherty,et al.  Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits , 1989, British journal of pharmacology.

[46]  T. Kita,et al.  Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits. , 1989, Arteriosclerosis.

[47]  G. Combs,et al.  Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E , 1989, British Journal of Nutrition.

[48]  O. Stein,et al.  Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. , 1989, Atherosclerosis.

[49]  Y. Sasaki,et al.  Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[50]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Sun,et al.  Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. , 1978, The Journal of nutrition.

[53]  M. L. Watson.  Staining of Tissue Sections for Electron Microscopy with Heavy Metals , 1958, The Journal of biophysical and biochemical cytology.

[54]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[55]  D. Steinberg,et al.  Role of oxidized LDL and antioxidants in atherosclerosis. , 1995, Advances in experimental medicine and biology.

[56]  A. Azzi,et al.  New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. , 1995, Biochemistry and molecular biology international.

[57]  R. Ross,et al.  Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.

[58]  E. Chatelain,et al.  d-α-tocopherol control of cell proliferation , 1993 .

[59]  J L Witztum,et al.  The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. , 1992, Annual review of medicine.

[60]  H. Esterbauer,et al.  Inhibition of LDL oxidation by antioxidants. , 1992, EXS.

[61]  P. Puska,et al.  Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. , 1991, The American journal of clinical nutrition.

[62]  A. Hofman,et al.  Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? , 1991, Atherosclerosis.

[63]  P. Henriksson,et al.  The antioxidant butylated hydroxytoluene protects against atherosclerosis. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.